HUTCHMED (China) Limited (HCM) Earnings History
Annual and quarterly earnings data from 2005 to 2024
Loading earnings history...
HCM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
HCM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 44.6% | -6.9% | 6.0% |
| 2023 | 54.1% | 2.2% | 12.0% |
| 2022 | 27.0% | -96.1% | -84.6% |
| 2021 | 27.5% | -96.7% | -54.7% |
| 2020 | 17.3% | -87.1% | -55.2% |
Download Data
Export HCM earnings history in CSV or JSON format
Free sign-in required to download data
HUTCHMED (China) Limited (HCM) Earnings Overview
As of May 8, 2026, HUTCHMED (China) Limited (HCM) reported trailing twelve-month net income of $467M, reflecting -63.3% year-over-year growth. The company earned $2.68 per diluted share over the past four quarters, with a net profit margin of 6.0%.
Looking at the long-term picture, HCM's historical earnings data spans multiple years. The company achieved its highest annual net income of $101M in fiscal 2023.
HUTCHMED (China) Limited maintains positive profitability with a gross margin of 44.6%, operating margin of -6.9%, and net margin of 6.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ZLAB (-$176M net income, -38.1% margin), LEGN (-$297M net income, -28.8% margin), CAN (-$210M net income, -39.7% margin), HCM has outperformed on profitability metrics. Compare HCM vs ZLAB →
HCM Earnings vs Peers
Earnings metrics vs comparable public companies
HCM Historical Earnings Data (2005–2024)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $38M | -62.6% | -$44M | $0.22 | 6.0% | -6.9% |
| 2023 | $101M | +127.9% | $18M | $0.60 | 12.0% | 2.2% |
| 2022 | -$361M | -85.4% | -$410M | $-2.15 | -84.6% | -96.1% |
| 2021 | -$195M | -54.8% | -$344M | $-1.25 | -54.7% | -96.7% |
| 2020 | -$126M | -21.3% | -$199M | $-0.90 | -55.2% | -87.1% |
| 2019 | -$104M | -38.6% | -$145M | $-1.10 | -50.6% | -70.8% |
| 2018 | -$75M | -179.8% | -$93M | $-0.55 | -34.9% | -43.3% |
| 2017 | -$27M | -328.6% | -$53M | $-0.22 | -11.1% | -22.1% |
| 2016 | $12M | +46.4% | -$47M | $0.10 | 5.4% | -21.6% |
| 2015 | $8M | +48.7% | -$10M | $-0.32 | 4.5% | -5.5% |
See HCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCM — Frequently Asked Questions
Quick answers to the most common questions about buying HCM stock.
Is HCM growing earnings?
HCM EPS fell to $2.68, with earnings declining -63.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $467M.
What are HCM's profit margins?
HUTCHMED (China) Limited net margin is +6.0%, with operating margin at -6.9%. Margins sit within typical range for the sector.
How consistent are HCM's earnings?
HCM earnings data spans 2005-2024. The declining earnings trend is -63.3% YoY. Historical data enables comparison across business cycles.